Hydroxyphenyllactic acid
CAS No. 306-23-0
Hydroxyphenyllactic acid( —— )
Catalog No. M29624 CAS No. 306-23-0
Hydroxyphenyllactic acid is an antifungal metabolite, fungi such as Lactobacillus sp. SK007.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 125 | In Stock |
|
| 50MG | 177 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | 410 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameHydroxyphenyllactic acid
-
NoteResearch use only, not for human use.
-
Brief DescriptionHydroxyphenyllactic acid is an antifungal metabolite, fungi such as Lactobacillus sp. SK007.
-
DescriptionHydroxyphenyllactic acid is an antifungal metabolite, fungi such as Lactobacillus sp. SK007.
-
In VitroHydroxyphenyllactic acid (4-hydroxyphenyllactic acid) is an antifungal metabolite.
-
In Vivo——
-
Synonyms——
-
PathwayProteasome/Ubiquitin
-
TargetEndogenous Metabolite
-
RecptorEndogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number306-23-0
-
Formula Weight182.175
-
Molecular FormulaC9H10O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (686.17 mM)
-
SMILESOC(Cc1ccc(O)cc1)C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
(R)-(-)-1,3-Butanedi...
(R)-(-)-1,3-Butanediol is a novel ketogenic ester that rapidly elevates circulating r- and s-?-hydroxybutyric acid levels in healthy adults, making it useful for studying metabolic system-related diseases.
-
5'-DEOXYADENOSINE
5'-Deoxyadenosine is an oxidized nucleoside found in the urine of normal subjects. Oxidized nucleosides represent excellent biomarkers for determining the extent of damage in genetic material which has long been of interest in understanding the mechanism of aging neurodegenerative diseases and carcinogenesis.
-
ADR-925
ADR-925, an active chelated iron metabolite of dexrazoxane, has the ability to protect neonatal rat cardiomyocytes from doxorubicin-induced injury.
Cart
sales@molnova.com